A detailed history of Aviva PLC transactions in Zoetis Inc. stock. As of the latest transaction made, Aviva PLC holds 591,196 shares of ZTS stock, worth $97.4 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
591,196
Previous 581,113 1.74%
Holding current value
$97.4 Million
Previous $101 Million 14.66%
% of portfolio
0.31%
Previous 0.29%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$172.58 - $196.48 $1.74 Million - $1.98 Million
10,083 Added 1.74%
591,196 $116 Million
Q2 2024

Aug 02, 2024

BUY
$145.54 - $178.83 $35.2 Million - $43.3 Million
241,970 Added 71.35%
581,113 $101 Million
Q1 2024

May 14, 2024

BUY
$165.67 - $199.94 $1.5 Million - $1.81 Million
9,063 Added 2.75%
339,143 $57.4 Million
Q4 2023

Feb 09, 2024

BUY
$151.44 - $200.09 $4.5 Million - $5.95 Million
29,727 Added 9.9%
330,080 $65.1 Million
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $2.51 Million - $2.9 Million
-15,033 Reduced 4.77%
300,353 $52.3 Million
Q2 2023

Aug 10, 2023

SELL
$160.94 - $186.23 $2.79 Million - $3.23 Million
-17,321 Reduced 5.21%
315,386 $54.3 Million
Q1 2023

May 12, 2023

SELL
$145.48 - $175.02 $1.09 Million - $1.31 Million
-7,474 Reduced 2.2%
332,707 $55.4 Million
Q4 2022

Feb 09, 2023

BUY
$131.14 - $157.47 $11.3 Million - $13.6 Million
86,254 Added 33.97%
340,181 $49.9 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $6.07 Million - $7.47 Million
40,922 Added 19.21%
253,927 $37.7 Million
Q2 2022

Aug 04, 2022

BUY
$155.97 - $200.09 $6.2 Million - $7.95 Million
39,722 Added 22.92%
213,005 $36.6 Million
Q1 2022

May 13, 2022

SELL
$181.39 - $234.03 $5.53 Million - $7.13 Million
-30,486 Reduced 14.96%
173,283 $32.7 Million
Q4 2021

Feb 10, 2022

BUY
$193.69 - $247.03 $663,388 - $846,077
3,425 Added 1.71%
203,769 $49.7 Million
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $4.28 Million - $4.74 Million
-22,627 Reduced 10.15%
200,344 $38.9 Million
Q2 2021

Aug 10, 2021

SELL
$155.9 - $187.99 $9.73 Million - $11.7 Million
-62,396 Reduced 21.87%
222,971 $41.6 Million
Q1 2021

May 13, 2021

BUY
$144.0 - $169.39 $1.37 Million - $1.61 Million
9,521 Added 3.45%
285,367 $44.9 Million
Q4 2020

Feb 10, 2021

BUY
$157.07 - $174.35 $13.5 Million - $15 Million
86,240 Added 45.48%
275,846 $45.7 Million
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $695,097 - $838,425
-5,070 Reduced 2.6%
189,606 $31.4 Million
Q2 2020

Aug 13, 2020

BUY
$111.92 - $142.53 $2.93 Million - $3.74 Million
26,221 Added 15.57%
194,676 $26.7 Million
Q1 2020

May 14, 2020

BUY
$92.66 - $144.94 $14,825 - $23,190
160 Added 0.1%
168,455 $19.8 Million
Q4 2019

Feb 10, 2020

SELL
$116.25 - $133.25 $87,885 - $100,737
-756 Reduced 0.45%
168,295 $22.3 Million
Q3 2019

Nov 12, 2019

SELL
$112.57 - $128.43 $1.11 Million - $1.26 Million
-9,827 Reduced 5.49%
169,051 $21.1 Million
Q2 2019

Jul 30, 2019

SELL
$97.98 - $114.28 $427,192 - $498,260
-4,360 Reduced 2.38%
178,878 $20.3 Million
Q1 2019

May 14, 2019

SELL
$81.56 - $100.67 $3.97 Million - $4.9 Million
-48,657 Reduced 20.98%
183,238 $18.4 Million
Q4 2018

Feb 12, 2019

SELL
$79.28 - $95.27 $53.7 Million - $64.5 Million
-677,210 Reduced 74.49%
231,895 $19.8 Million
Q3 2018

Nov 13, 2018

SELL
$83.5 - $93.23 $847,608 - $946,377
-10,151 Reduced 1.1%
909,105 $83.2 Million
Q2 2018

Aug 01, 2018

SELL
$79.9 - $89.2 $22.5 Million - $25.2 Million
-282,010 Reduced 23.48%
919,256 $78.3 Million
Q1 2018

May 14, 2018

BUY
$71.51 - $84.69 $17.3 Million - $20.5 Million
242,301 Added 25.27%
1,201,266 $100 Million
Q4 2017

Feb 13, 2018

SELL
$63.24 - $72.8 $39,208 - $45,136
-620 Reduced 0.06%
958,965 $69.1 Million
Q3 2017

Nov 13, 2017

BUY
$59.73 - $65.4 $125,433 - $137,340
2,100 Added 0.22%
959,585 $61.2 Million
Q2 2017

Aug 07, 2017

BUY
N/A
957,485
957,485 $59.7 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.